New Window of Opportunity “WOO” funding awarded to Drs. Serrano and Meyers

The Ontario Institute for Cancer Research (OICR) has awarded Drs. Pablo Serrano and Brandon Meyers $400,000 for their new clinical trial Radiation Therapy followed by Durvalumab / Tremelimumab and Surgery versus Radiation Therapy followed by Surgery for Resectable Hepatocellular Carcinoma. A Randomized Window of Opportunity “WOO” Trial (DARTS).

READ the full story here